Joseph Fralin Woody - 17 Mar 2021 Form 4/A - Amendment Insider Report for Avanos Medical, Inc. (AVNS)

Role
Chief Executive Officer, Director
Signature
/s/ Ross Mansbach , as attorney-in-fact for Joseph F. Woody
Issuer symbol
AVNS
Transactions as of
17 Mar 2021
Net transactions value
+$2,812,667
Form type
4/A - Amendment
Filing time
10 Sep 2021, 16:08:55 UTC
Date Of Original Report
19 Mar 2021
Next filing
08 Mar 2022
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction AVNS Common Stock Award $2,812,667 +59,477 +38% $47.29 214,049 17 Mar 2021 Direct F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 This Form 4/A is being filed to correct the original number of shares issued to the Reporting Person on 3/17/2021. The original filing reported 56,147 shares issued, whereas the correct number of shares issued were 59,477. This represents an annual grant of time-vested restricted stock units awarded to the Reporting Person on 3/17/2021, with a 3 year cliff vesting period.
F2 Total beneficially owned shares include 755 shares acquired on 12/31/2019 and 735 shares on 6/30/2020 under the Issuer's Employee Stock Purchase.